Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sanofi-Aventis
Relationship:   10% Owner
City:   Paris
State:   I0
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   75,668,031    

Indirect Shares

   26,048,661      
Direct Value   $2,826,957,638    

Indirect Value

   $1,869,919,512      
Total Shares   101,716,692      
Total Value   $4,696,877,150      


Translate Bio, Inc. $2,826,957,638 Translate Bio, Inc. $2,826,957,638
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    5    

     Stock price went up :
    0   
    2    
     Stock price went down :
    1   
    3    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -17.8%
 -3.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2014-02-04 5,053,779    Premium*  
            Humanigen Inc HGEN Former 10% owner 2013-01-31 0 2013-01-31 579,030    Premium*  
            Glycomimetics Inc GLYC 10% Owner 0 2013-11-06 1,193,625    Premium*  
            Regeneron Pharmaceuticals Inc REGN 2020-05-29 0 2020-06-09 279,766    Premium*  
            Alnylam Pharmaceuticals Inc ALNY 10% Owner 0 2017-05-31 10,554,134    Premium*  
            Scynexis Inc SCYX 10% Owner 0 2014-05-07 1,677,057    Premium*  
            Voyager Therapeutics, Inc. VYGR Former 10% owner 2015-11-10 0 2015-11-16 2,477,941    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 2019-07-22 0 2019-07-22 558,035    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 520,125    Premium*  
            Icosavax, Inc. ICVX 10% Owner 2021-08-02 0 2021-08-02 3,155,169    Premium*  
            Translate Bio, Inc. TBIO 10% Owner 2021-09-14 75,668,031 2021-09-14 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
REGN Regeneron Pharmaceuticals...   •       •       •   2020-05-29 4 S $509.85 $2,147,483,647 D/D (20,421,899) 0 0 %
TBIO Translate Bio, Inc. 10% Owner   –       –       •   2021-09-14 4 B $38.00 $2,147,483,647 D/D 71,983,597 75,668,031 2.45 %
ALNY Alnylam Pharmaceuticals I... 10% Owner   –       –       •   2015-01-22 4 B $9,317.00 $1,828,470,567 I/I 196,251 9,307,037 1.5 -
REGN Regeneron Pharmaceuticals...   •       •       •   2020-05-29 4 S $509.85 $1,223,411,587 I/I (2,399,552) 400,000 0 %
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-21 4 B $313.12 $98,008,222 I/I 305,115 18,483,365 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-27 4 B $302.96 $95,463,963 I/I 306,945 19,711,145 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-24 4 B $299.01 $94,511,734 I/I 306,945 18,790,310 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-28 4 B $300.28 $94,149,583 I/I 306,945 20,018,090 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-03 4 B $328.00 $85,070,118 I/I 251,594 17,001,214 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-07 4 B $327.77 $80,405,733 I/I 241,818 17,393,309 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-07 4 AB $311.17 $80,320,795 I/I 256,700 21,252,741 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2015-09-23 4 B $523.43 $78,708,570 I/I 147,209 23,016,992 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-12 4 B $325.40 $73,964,412 I/I 220,995 17,994,836 1.5 -
REGN Regeneron Pharmaceuticals...   •       •       •   2020-06-09 4 S $597.48 $71,837,410 I/I (120,234) 279,766 0 %
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-12-23 4 B $384.43 $67,251,142 I/I 171,457 22,829,142 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-10 4 B $325.34 $65,687,435 I/I 199,822 17,593,131 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-02 4 AB $298.91 $65,259,552 I/I 212,400 20,896,041 0 -
REGN Regeneron Pharmaceuticals...   •       •       •   2017-06-02 4 B $466.38 $65,055,558 I/I 136,050 23,641,744 2.64 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-01 4 AB $285.89 $63,761,421 I/I 212,400 20,683,641 0 -
REGN Regeneron Pharmaceuticals...   •       •       •   2020-03-09 4 S $489.65 $63,123,153 D/D (128,914) 20,421,899 0 %
ALNY Alnylam Pharmaceuticals I... 10% Owner   –       –       •   2015-01-26 4 B $95.00 $61,507,560 I/I 647,448 9,954,485 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-09 4 AB $304.19 $60,112,311 I/I 195,000 21,600,741 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-11 4 B $328.82 $60,043,336 I/I 180,710 17,773,841 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-06-30 4 AB $275.68 $60,010,479 I/I 212,400 20,471,241 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-02-05 4 B $274.64 $58,367,107 I/I 206,978 16,581,109 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us